{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:11:48Z","timestamp":1790723508735,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.gtc.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T22:48:51Z","timestamp":1503701331000},"page":"515-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Sushil K.","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando S.","family":"Velayos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib3","first-page":"1119","article-title":"Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer","volume":"32","author":"Franks","year":"2012","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark","volume":"19","author":"Jess","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gtc.2017.05.006_bib6","series-title":"SEER cancer statistics review, 1975-2013","year":"2016"},{"issue":"29","key":"10.1016\/j.gtc.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3748\/wjg.v18.i29.3839","article-title":"Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?","volume":"18","author":"Dyson","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1471-4914(01)02194-3","article-title":"Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared","volume":"8","author":"Rhodes","year":"2002","journal-title":"Trends Mol Med"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010","volume":"143","author":"Herrinton","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOG.0000000000000286","article-title":"Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?","volume":"32","author":"Garg","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib14","first-page":"571","article-title":"Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study","volume":"11","author":"Hovde","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.30183","article-title":"Inflammatory bowel disease, cancer and medication: cancer risk in the Dutch population-based IBDSL cohort","volume":"139","author":"van den Heuvel","year":"2016","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A\u00a0genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3748\/wjg.14.378","article-title":"Cancer in inflammatory bowel disease","volume":"14","author":"Xie","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1756283X13487941","article-title":"Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view","volume":"6","author":"Kisiel","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","article-title":"Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis","volume":"25","author":"Thomas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2009.12.035","article-title":"AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clcc.2016.02.002","article-title":"Colorectal cancer in patients with inflammatory bowel disease: the need for a real surveillance program","volume":"15","author":"Fornaro","year":"2016","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","article-title":"Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment","volume":"46","author":"Aparicio","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11605-010-1402-9","article-title":"Intestinal cancer risk in Crohn's disease: a meta-analysis","volume":"15","author":"Laukoetter","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.gtc.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000273784","article-title":"Malignancy in Crohn's disease: incidence and clinical characteristics in Japan","volume":"81","author":"Mizushima","year":"2010","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1008988215904","article-title":"Crohn's disease and cancer risk (Denmark)","volume":"11","author":"Mellemkjaer","year":"2000","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/00365528609034627","article-title":"Malignancy in Crohn's disease","volume":"21","author":"Kvist","year":"1986","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.gtc.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1440-1746.2012.07082.x","article-title":"Intestinal cancers occurring in patients with Crohn's disease","volume":"27","author":"Kamiya","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s10350-003-0101-y","article-title":"Small bowel adenocarcinoma at a strictureplasty site in a patient with Crohn's disease: report of a case","volume":"47","author":"Partridge","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10350-006-0771-3","article-title":"Adenocarcinoma of the small bowel arising from a previous strictureplasty for Crohn's disease: report of a case","volume":"50","author":"Menon","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02234306","article-title":"Adenocarcinoma at a strictureplasty site in Crohn's disease: report of a case","volume":"44","author":"Jaskowiak","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.gtc.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1440-1746.1999.02020.x","article-title":"Case report: adenocarcinoma arising in a Crohn's stricture of the jejunum","volume":"14","author":"Barwood","year":"1999","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(19890115)63:2<360::AID-CNCR2820630227>3.0.CO;2-9","article-title":"Small bowel carcinoma in Crohn's disease. Distinguishing features and risk factors","volume":"63","author":"Senay","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM197007162830308","article-title":"Adenocarcinoma arising in an excluded loop of ileum","volume":"283","author":"Schuman","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib38","first-page":"122","article-title":"Cancer in Crohn's disease. The danger of a by-passed loop","volume":"64","author":"Greenstein","year":"1975","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.006_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00054725-200401000-00005","article-title":"Small intestinal adenocarcinoma in Crohn's disease: a case-control study","volume":"10","author":"Solem","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.gtc.2017.05.006_bib40","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1572-0241.2008.01847.x","article-title":"Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study","volume":"103","author":"Piton","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1148\/rg.325115088","article-title":"Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease","volume":"32","author":"Amzallag-Bellenger","year":"2012","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.006_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.crohns.2013.04.006","article-title":"Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)","volume":"8","author":"Magro","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.gtc.2017.05.006_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib45","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","article-title":"Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis","volume":"146","author":"Panaccione","year":"2014","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2017.05.006_bib46","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2013.441","article-title":"Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT Registry","volume":"109","author":"Lichtenstein","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.006_bib48","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ibd.21305","article-title":"Lost in translation: helping patients understand the risks of inflammatory bowel disease therapy","volume":"16","author":"Siegel","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.gtc.2017.05.006_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"9701","key":"10.1016\/j.gtc.2017.05.006_bib50","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib51","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2013.12.025","article-title":"Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease","volume":"146","author":"Osterman","year":"2014","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gtc.2017.05.006_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11894-015-0467-8","article-title":"Monitoring for extra-intestinal cancers in IBD","volume":"17","author":"Sifuentes","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","article-title":"Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib56","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.suc.2014.07.013","article-title":"Epidemiology, risk factors, prevention, and early detection of melanoma","volume":"94","author":"Azoury","year":"2014","journal-title":"Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib57","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib58","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","article-title":"Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study","volume":"136","author":"Singh","year":"2009","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.006_bib60","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib61","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.006_bib62","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/DCR.0000000000000700","article-title":"Fistula-associated anorectal cancer in the setting of Crohn's disease","volume":"59","author":"Shwaartz","year":"2016","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.006_bib63","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn's disease","volume":"50","author":"von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.gtc.2017.05.006_bib64","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/DCR.0b013e31822bbcc1","article-title":"Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis","volume":"54","author":"Lindstrom","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"9252","key":"10.1016\/j.gtc.2017.05.006_bib65","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(00)03612-6","article-title":"Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study","volume":"357","author":"Askling","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib66","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.2004.051771","article-title":"Risk of haematopoietic cancer in patients with inflammatory bowel disease","volume":"54","author":"Askling","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.006_bib67","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.006_bib68","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.006_bib69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.006_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ajg.2013.451","article-title":"Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis","volume":"109","author":"Ariyaratnam","year":"2014","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T09:00:32Z","timestamp":1535446832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855317300602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0889855317300602"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2017.05.006","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}